<!DOCTYPE html>
<html lang="en">
  
<!-- Mirrored from www.allindianpatents.com/patents/233487-solid-dispersion-composition by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 13:44:07 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=Edge,chrome=1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Indian Patents. 233487:&quot;SOLID DISPERSION COMPOSITION&quot;</title>
    <meta content="authenticity_token" name="csrf-param" />
<meta content="cYcP52B8zyTWKbLwby2YPh9z/gvY/RLjWOwY4YXkiXg=" name="csrf-token" />

    <!-- Le HTML5 shim, for IE6-8 support of HTML elements -->
    <!--[if lt IE 9]>
      <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.6.1/html5shiv.js" type="text/javascript"></script>
    <![endif]-->

    <link href="../assets/application-e80cf34975c5b1730c80b2f7170e7d26.css" media="all" rel="stylesheet" type="text/css" />

  </head>
  <body>

    <div class="navbar navbar-fluid-top">
      <div class="navbar-inner">
        <div class="container-fluid">
          <a class="btn btn-navbar" data-target=".nav-collapse" data-toggle="collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </a>
          <a class="brand" href="../index.html">Indian Patents</a>
          <div class="container-fluid nav-collapse">
            <ul class="nav">
              <li><a href="../recently-granted.html">Recently Granted Patents</a></li>
              <li><a href="../recently-published.html">Recently Published Patents</a></li>
            </ul>
            <form id="gform" class="navbar-search pull-right" action="https://www.google.com/search" method="get" target="_blank" onsubmit="document.getElementById('gform').q.value='site:http://www.allindianpatents.com '+document.getElementById('gform').q.value">
                <input type="text" name="q" id="q" class="search-query" placeholder="Search" onclick="this.value=''" autocomplete="off">
            </form>
          </div><!--/.nav-collapse -->
        </div>
      </div>
    </div>

    <div class="container-fluid">
      <div class="row-fluid">
        <div class="span12">

          <style>
          .allindianpatents-top { width: 320px; height: 50px; }
          @media(min-width: 500px) { .allindianpatents-top { width: 468px; height: 60px; } }
          @media(min-width: 800px) { .allindianpatents-top { width: 728px; height: 90px; } }
          </style>
          <center>
          </center>
          
          <div class="row-fluid">
	<div class="span8">

		<table class="table">
			<tr>
				<th>Title of Invention</th>
				<td><h1 style="font-size:large;">&quot;SOLID DISPERSION COMPOSITION&quot;</h1></td>
			</tr>
			<tr>
				<th>Abstract</th>
				<td>The invention provides a solid dispersion composition containing 2-benzyl-5-(4-chlorophenyl)-6-[4-(methylthio)phenyl]-2H-pyridazin-3-one, hydroxypropylmethyl cellulose, and polyoxyethylene polyoxypropylene glycol. The solid dispersion composition of the present invention exhibits the excellent dissolvability of 2-benzyl-5-(4-chlorophenyl)-6-[4-(methylthio)phenyl]-2H-pyridazin-3-one in water, and enables this compound to be constant sequentially and thereby improve absorbability in blood.</td>
			</tr>
		</table>

					<style>
					.allindianpatents-post-abstract { width: 320px; height: 50px; }
					@media(min-width: 880px) { .allindianpatents-post-abstract { width: 468px; height: 60px; } }
					@media(min-width: 1267px) { .allindianpatents-post-abstract { width: 728px; height: 90px; } }
					</style>
					<center>
					<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
					<!-- AllIndianPatents-post-abstract -->
					<ins class="adsbygoogle allindianpatents-post-abstract"
					     style="display:inline-block"
					     data-ad-client="ca-pub-7914358224572760"
					     data-ad-slot="9152759240"></ins>
					<script>
					(adsbygoogle = window.adsbygoogle || []).push({});
					</script>					
					</center>

		<table class="table">
			<tr>
				<th>Full Text</th>
				<td>Solid Dispersion Composition<br>
BACKGROUND OF THE INVENTION<br>
Field of the Invention<br>
The present invention relates to a solid dispersion<br>
composition containing 2-benzyl-5-(4-chlorophenyl)-6-[4-<br>
(methylthio)phenyl]-2H-pyridazin-3-one (hereinafter referred<br>
to as "compound 1"), which has excellent dissolvability and<br>
dissolution stability alike.<br>
Background Art<br>
Compound 1, which exerts an excellent effect for<br>
suppressing production of interleukin 10, is known to be<br>
useful as a prophylactic and therapeutic agent for<br>
immunological diseases, inflammatory diseases, and ischemic<br>
diseases, particularly as a therapeutic agent for articular<br>
rheumatism (disclosed in Japanese Patent Application Laid-<br>
Open (kokai) No. 2000-198776).<br>
The present inventors have conducted studies on use of<br>
the aforementioned compound 1 in a peroral pharmaceutical<br>
composition. However, compound 1 has exceptionally poor<br>
solubility in water, and its dissolvability from the<br>
pharmaceutical composition is very bad. Thus, such a<br>
composition proved impossible to satisfy sufficient<br>
pharmaceutical effects.<br>
Generally, dissolvability in water of a poor water<br>
dissoluble drug in a pharmaceutical composition is known to<br>
be improved by micro-pulverization of the drug and/or<br>
transformation of the drug into a derivative thereof.<br>
However, in the case of compound 1, micro-pulverization does<br>
not work; i.e., dissolvability is not improved, and<br>
transformation into a derivative results in unwanted changes<br>
in pharmaceutical effect.<br>
Accordingly, the purpose of the present invention is to<br>
enhance the dissolvability of compound 1 from a<br>
pharmaceutical composition and thus provide the<br>
pharmaceutical composition containing said compound, which<br>
has the excellent dissolution stability with allowing said<br>
compound to keep a constant concentration after dissolving<br>
from the composition.<br>
SUMMARY OF THE INVENTION<br>
The present inventors have prepared compositions<br>
containing compound 1 and a variety of other components and<br>
investigated dissolvability of compound 1 contained in these<br>
compositions, and have found that, when a dispersion<br>
composition in solid form (hereinafter referred to as a solid<br>
dispersion composition) is prepared from compound 1,<br>
hydroxypropylmethyl cellulose and polyoxyethylene<br>
polyoxypropylene glycol, dissolvability of compound 1 can be<br>
remarkably enhanced; that the concentration of compound 1 can<br>
be constant after dissolving from the composition; and that a<br>
composition useful as a peroral pharmaceutical can be<br>
obtained from the solid dispersion composition. The present<br>
invention has been accomplished on the basis of these<br>
findings.<br>
Thus, the present invention provides a solid dispersion<br>
composition comprising compound I, hydroxypropylmethyl<br>
cellulose and polyoxyethylene polyoxypropylene glycol.<br>
In another aspect of the present invention, there is<br>
provided a readily dissoluble pharmaceutical composition<br>
comprising a solid dispersion composition containing compound<br>
1, hydroxypropylmethyl cellulose and polyoxyethylene<br>
polyoxypropylene glycol, and a pharmacologically acceptable<br>
carrier.<br>
DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS<br>
Compound 1 employed in the present invention; i.e., 2-<br>
benzyl-5-(4-chlorophenyl)-6-[4-(methylthio)phenyl]-2Hpyridazin-<br>
3-one, can be produced through any known method,<br>
such as a method disclosed in Japanese Patent Application<br>
Laid-Open (kokai) No. 2000-198776.<br>
Preferably, the solid dispersion composition of the<br>
present invention contains compound 1 in an amount of 0.1-35<br>
wt.%, more preferably 1-30 wt.%, particularly preferably 5-25<br>
wt.%.<br>
The hydroxypropylmethyl cellulose which is employed in<br>
the present invention has a methoxy group content of 19-30<br>
wt.%, preferably 28-30 wt.%, and a hydroxypropoxy group<br>
content of 4-12 wt.%, preferably 7-12 wt.%. More preferably,<br>
the hydroxypropylmethyl cellulose has a viscosity of 2.5-7<br>
mm2/s (20°C) . As used herein, viscosity is that measured at<br>
3<br>
20°C through a viscosity determination method 1 described in<br>
Japanese Pharmacopoeia (i.e., capillary tube viscometer<br>
method) by use of an aqueous solution in which a sample (2 g)<br>
is dissolved in water (98 mL). Specific examples include<br>
hydroxypropylmethyl cellulose 2208, hydroxypropylmethyl<br>
cellulose 2906, and hydroxypropylmethyl cellulose 2910; and,<br>
as commercial products, Metolose 90SH, Metolose 65SH,<br>
Metolose GOSH, TC-5E, TC-5R and TC-5S (product of Shin-Etsu<br>
Chemical Co., Ltd.); Metocel K, Metocel F, and Metocel E<br>
(product of Dow Chemical Co.); and Marpolose (product of<br>
Matsumoto Yushi-Seiyaku Co., Ltd.).<br>
Preferably, hydroxypropylmethyl cellulose is<br>
incorporated in an amount of 2-15 parts by weight based on 1<br>
part by weight of compound 1, particularly preferably 3-10<br>
parts by weight.<br>
Preferably, the polyoxyethylene polyoxypropylene glycol<br>
which is employed in the present invention has the mean<br>
degree of polymerization of ethylene oxide of 3-200, more<br>
preferably 54-196, particularly preferably 105-160, and the<br>
mean degree of polymerization of propylene oxide of 5-70,<br>
more preferably 5-40, particularly preferably 5-30.<br>
Examples of polyoxyethylene polyoxypropylene glycol<br>
species include polyoxyethylene(105) polyoxypropylene(5)<br>
glycol, polyoxyethylene(120) polyoxypropylene(40) glycol,<br>
polyoxyethylene(160) polyoxypropylene(30) glycol,<br>
polyoxyethylene(196) polyoxypropylene(67) glycol,<br>
polyoxyethylene(20) polyoxypropylene(20) glycol,<br>
polyoxyethylene(200) polyoxypropylene(70) glycol,<br>
polyoxyethylene(3) polyoxypropylene(17) glycol,<br>
polyoxyethylene(42) polyoxypropylene(67) glycol, and<br>
polyoxyethylene(54) polyoxypropylene(39) glycol; and, as<br>
commercial products, PEP 101 (product of Freund Industrial<br>
Co., Ltd.); Adeka Pluronic F-87, Adeka Pluronic L-44, Adeka<br>
Pluronic F-68, and Adeka Pluronic L-31 (product of Asahi<br>
Denka Kogyo co., Ltd.); and Unilube, Unilube 40DP-40B,<br>
Unilube 70DP-950B, and Plonon (product of Nippon Oil &amp; Fats<br>
Co., Ltd.). The parenthetic number refers to the mean degree<br>
of polymerization of ethylene oxide or propylene oxide.<br>
Preferably, polyoxyethylene polyoxypropylene glycol is<br>
incorporated in an amount of 0.01-3 parts by weight based on<br>
1 part by weight of compound 1, particularly preferably 0.1-1<br>
parts by weight.<br>
In a preferred mode, the three-component solid<br>
dispersion composition is produced by dissolving three<br>
components in a solvent and removing the solvent through the<br>
method as described hereinafter.<br>
The solvent is selected on the solubility of these<br>
three components. Examples thereof include organic solvents<br>
such as methyl alcohol, ethyl alcohol, isopropyl alcohol,<br>
acetone, and dichloromethane; mixtures thereof; and mixtures<br>
thereof with water.<br>
No particular limitation is imposed on the method of<br>
removing the solvent, and any method can be employed so long<br>
as the method enables removal of the solvent. Examples of<br>
the method include evaporation under reduced pressure/-<br>
atomizing the solution by means of a spray dryer; and<br>
applying the solution to core particles (lactose,<br>
microcrystalline cellulose, anhydrous dibasic calcium<br>
phosphate, etc.) placed in an apparatus such as a fluid bed<br>
granulator or a rotary granulator, to thereby cause the<br>
solvent to be evaporated.<br>
While the solid dispersion composition of the present<br>
invention is required to contain hydroxypropylmethyl<br>
cellulose and polyoxyethylene polyoxypropylene glycol, the<br>
effects of the present invention remain persistent even when<br>
other ingredients are added thereto.<br>
From the standpoint of dissolvability of compound 1,<br>
the solid dispersion composition preferably has an average<br>
particle size of 1-1,000 (im, more preferably 2-800 jam,<br>
particularly preferably 10-600 jam. As used herein, the<br>
average particle size refers to an average particle size as<br>
measured through a laser beam scattering diffraction method.<br>
The readily-dissoluble pharmaceutical composition of<br>
the present invention may serve either as a solid dispersion<br>
composition which has beforehand been prepared to comprise<br>
comopound 1, hydroxypropylmethyl cellulose and<br>
polyoxyethylene polyoxypropylene glycol, or as a readilydissoluble<br>
pharmaceutical composition mixed in various forms<br>
with a pharmacologically acceptable carrier. For the present<br>
invention, the latter composition is preferred from the<br>
viewpoint of dissolvability.<br>
Examples of the pharmacologically acceptable carrier<br>
include excipients such as lactose, microcrystalline<br>
cellulose, sucrose, mannitol, light anhydrous silicic acid,<br>
and dibasic calcium phosphate; binders such as methyl<br>
cellulose, hydroxypropyl cellulose, gelatin,<br>
polyvinylpyrrolidone, and pullulan; disintegrants such as<br>
croscarmelose sodium, carmellose calcium, cros povidone and<br>
low-substituted hydroxypropyl cellulose; lubricants such as<br>
magnesium stearate and talc; colorants such as tar pigments<br>
and red ferric oxide; and flavoring agents such as stevia,<br>
aspartame, and perfume.<br>
No particular limitation is imposed on the form of the<br>
dissolution-facilitating pharmaceutical composition of the<br>
present invention, and any form is acceptable so long as it<br>
is a solid form. Examples of forms for easy ingestion<br>
include tablets, capsules, granules, and fine granules.<br>
EXAMPLES<br>
The present invention will be described in more detail<br>
by way of Examples and Comparative Examples, which should not<br>
be construed as limiting the invention thereto.<br>
Example 1<br>
Compound 1 (150 g), hydroxypropylmethyl cellulose<br>
(methoxy group content: 29 wt.%, hydroxypropoxy group<br>
content: 10 wt.%) (TC-5R, product of Shin-Etsu Chemical Co.,<br>
Ltd.) (450 g), and polyoxyethylene(105) polyoxypropylene(5)<br>
glycol (PEP 101, product of Freund Industrial Co., Ltd.) (30<br>
g) were added to an ethylalcohol/acetone/water mixture<br>
(proportions by volume: 9/10/1) (24 L) with stirring at 50°C,<br>
to thereby dissolve these ingredients. The thus-prepared<br>
solution was applied to lactose (300 g) placed in a fluid bed<br>
granulator, and granulation was performed, to thereby yield<br>
granules of a solid dispersion composition.<br>
The average particle size of the granules, as measured<br>
by means of a particle size distribution measurement<br>
apparatus of laser beam scattering diffraction type (LS 230,<br>
product of Beckmann &amp; Coulter), was found to be 327 ^m. This<br>
method of measurement was also applied to the following<br>
Examples and Comparative Examples.<br>
Example 2<br>
The procedure of Example 1 was repeated, except that<br>
polyoxyethylene(160) polyoxypropylene(30) glycol (Adeka<br>
Pluronic F-68, product of Asahi Denka Kogyo Co., Ltd.) was<br>
used instead of polyoxyethylene(105) polyoxypropylene(5)<br>
glycol (PEP 101, product of Freund Industrial Co., Ltd.), to<br>
thereby yield granules of a solid dispersion composition<br>
(average particle size: 386 (im) .<br>
Comparative Example 1<br>
Compound 1 (15 g), hydroxypropylmethyl cellulose (the<br>
same as used in Example 1)(45 g) , and polyxoyethylene (105)<br>
polyoxypropylene (5) glycol (the same as used in Example 1)(3<br>
g) were mixed together in a mortal, to thereby yield powder.<br>
Comparative Example 2<br>
Compound 1 (15 g) and hydroxypropylmethyl cellulose<br>
(the same as used in Example 1) (45 g) were added to an<br>
ethylalcohol/acetone/water mixture (proportions by volume:<br>
9/10/1) (2400 mL) with stirring at 50°C, to thereby dissolve<br>
these ingredients. The thus-prepared solution was atomized<br>
by means of a spray dryer, to thereby yield a solid<br>
dispersion powder (average particle size: 21 (j.m) .<br>
Comparative Example 3<br>
Compound 1 (15 g) , hydroxypropylmethyl cellulose (the<br>
same as used in Example 1) (45 g), glyceryl monostearate<br>
(Nikkol MGS-B, product of Nikko Chemicals Co., Ltd.) (1.5 g),<br>
and polyoxyl 40 stearate (Nikkol MYS-40, product of Nikko<br>
Chemicals Co., Ltd.) (3 g) were added to an<br>
ethylalcohol/acetone/water mixture (proportions by volume:<br>
9/10/1) (2400 mL) with stirring at 50°C, to thereby dissolve<br>
these ingredients. The thus-prepared solution was atomized<br>
by means of a spray dryer, to thereby yield a solid<br>
dispersion powder (average particle size: 18 urn).<br>
Comparative Example 4<br>
Compound 1 (15 g)/ hydroxypropylmethyl cellulose (the<br>
same as used in Example 1) (45 g), and polysorvate 80 (Nikkol<br>
TO-10M, product of Nikko Chemicals Co., Ltd.) (7.5 g) were<br>
added to an ethylalcohol/acetone/water mixture (proportions<br>
by volume: 9/10/1) (2400 mL) with stirring at 50°C, to<br>
thereby dissolve these ingredients. The thus-prepared<br>
solution was atomized by means of a spray dryer, to thereby<br>
yield the powder of a solid dispersion composition (average<br>
particle size: 26 (im) .<br>
Test Example 1 Dissolution test<br>
The solid dispersion compositions produced in Examples<br>
1 and 2 and Comparative Examples 1 to 4 were confirmed in<br>
terms of the dissolvability of compound 1 and the dissolution<br>
stability, as follows.<br>
Dissolution test:<br>
Dissolution test 2 (paddle method), in accordance with<br>
general test methods (Japanese Pharmacopoeia)<br>
A solid dispersion composition containing compound 1<br>
(10 mg) was placed in water (900 mL), and the mixture was<br>
stirred at 37 ± 1°C and a paddle rotation speed of 50 r/min,<br>
to measure a concentration of compound 1 at each time of 5,<br>
30, 60 and 120 minutes thereafter. The sample solution<br>
collected at each time was filtered using a cellulose acetate<br>
membrane filter with 0.45 11 m pore size (DISMIC-25cs, product<br>
of Toyo Roshi), and the following results in Table 1 were<br>
obtained by HPLC using a reverse phase column (Inertsil ODS-2,<br>
product of GL Science).<br>
Thus, the dissolvability of compound 1 into water was<br>
little observed in the case of Comparative Example 1 where<br>
compound 1 was merely mixed with hydroxypropylmethyl<br>
cellulose and plyoxyethylene polyoxypropylene glycol, as well<br>
as in the case of Comparative Example 2 where a solid<br>
dispersion composition was prepared by mixing compound 1 with<br>
only hydroxypropylmethyl cellulose, not with polyoxyethylene<br>
polyoxypropylene glycol. In the cases of Comparative<br>
Examples 3 and 4 where solid dispersion compositions were<br>
prepared by adding thereto a surfactant of the other type,<br>
compound 1 was able to dissolve into water in early phase,<br>
but its concentration decreased sequentially. In the<br>
contrast with such cases, the solid dispersion compositions<br>
of Examples 1 and 2, which were prepared by mixing compound 1<br>
with both hydroxypropylmethyl cellulose and polyoxyethylene<br>
polyoxypropylene glycol, were confirmed to have excellent<br>
dissolvability of compound 1 in water, and to enable compound<br>
1 to keep a constant concentration sequentially.<br>
Example 3<br>
Granules of the solid dispersion composition produced<br>
in Example 1 (62 g), lactose (160 g), carmelose calcium (36<br>
g), and light anhydrous silicic acid (2 g) were mixed, and<br>
the mixture was compressed by use of a tablet compress, to<br>
thereby obtain tablets (0.26 g/tablet, diameter: 8.5 mm).<br>
The obtained tablets showed the same dissolvability as that<br>
achieved by the solid dispersion granules of Example 1.<br>
Industrial Applicability of the Invention<br>
The solid dispersion composition of the present<br>
invention exhibits the excellent dissolvability of 2-benzyl-<br>
5-(4-chlorophenyl)-6-[4-(methylthio)phenyl]-2H-pyridazin-3-<br>
one in water and allows the concentration of this compound to<br>
keep constant sequentially, which is also superior in<br>
dissolution stability.<br><br>
We claim:<br>
1.	A     solid     dispersion     composition     containing     (A)     2-benzyl-5-(4-<br>
chlorophenyl) - 6- [4 - (methylthio)phenyl] -2 H-pyridazin-3 -one,	(B)<br>
hydroxypropylmethyl cellulose, and (C) polyoxyethylene polyoxypropylene<br>
glycol, wherein the components (A) and (B) are added at a weight ratio<br>
(A)/(B)= 1: 2 to 15, and the components (A) and (C) are added at a weight<br>
ratio (A)/(C) =1: 0.01 to 3.<br>
2.	A readily dissoluble pharmaceutical compositions comprising the solid<br>
dispersion composition as claimed in claim 1 and a pharmacologically<br>
acceptable carrier.<br><br></td>
			</tr>
		</table>	
		<br>
		<h3>Documents:</h3>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjkxNy1ERUxOUC0yMDA0LUFic3RyYWN0LTA4LTA1LTIwMDgucGRm" target="_blank" style="word-wrap:break-word;">2917-DELNP-2004-Abstract-08-05-2008.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjkxNy1kZWxucC0yMDA0LWFic3RyYWN0LnBkZg==" target="_blank" style="word-wrap:break-word;">2917-delnp-2004-abstract.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjkxNy1ERUxOUC0yMDA0LUNsYWltcy0wOC0wNS0yMDA4LnBkZg==" target="_blank" style="word-wrap:break-word;">2917-DELNP-2004-Claims-08-05-2008.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjkxNy1kZWxucC0yMDA0LWNsYWltcy5wZGY=" target="_blank" style="word-wrap:break-word;">2917-delnp-2004-claims.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjkxNy1ERUxOUC0yMDA0LUNvcnJlc3BvbmRlbmNlLU90aGVycy0wOC0wNS0yMDA4LnBkZg==" target="_blank" style="word-wrap:break-word;">2917-DELNP-2004-Correspondence-Others-08-05-2008.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjkxNy1kZWxucC0yMDA0LWNvcnJlc3BvbmRlbmNlLW90aGVycy5wZGY=" target="_blank" style="word-wrap:break-word;">2917-delnp-2004-correspondence-others.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjkxNy1kZWxucC0yMDA0LWRlc2NyaXB0aW9uIChjb21wbGV0ZSktMDgtMDUtMjAwOC5wZGY=" target="_blank" style="word-wrap:break-word;">2917-delnp-2004-description (complete)-08-05-2008.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjkxNy1kZWxucC0yMDA0LWRlc2NyaXB0aW9uIChjb21wbGV0ZSkucGRm" target="_blank" style="word-wrap:break-word;">2917-delnp-2004-description (complete).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjkxNy1kZWxucC0yMDA0LWZvcm0tMS5wZGY=" target="_blank" style="word-wrap:break-word;">2917-delnp-2004-form-1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjkxNy1kZWxucC0yMDA0LWZvcm0tMTgucGRm" target="_blank" style="word-wrap:break-word;">2917-delnp-2004-form-18.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjkxNy1ERUxOUC0yMDA0LUZvcm0tMi0wOC0wNS0yMDA4LnBkZg==" target="_blank" style="word-wrap:break-word;">2917-DELNP-2004-Form-2-08-05-2008.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjkxNy1kZWxucC0yMDA0LWZvcm0tMi5wZGY=" target="_blank" style="word-wrap:break-word;">2917-delnp-2004-form-2.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjkxNy1ERUxOUC0yMDA0LUZvcm0tMy0wOC0wNS0yMDA4LnBkZg==" target="_blank" style="word-wrap:break-word;">2917-DELNP-2004-Form-3-08-05-2008.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjkxNy1kZWxucC0yMDA0LWZvcm0tMy5wZGY=" target="_blank" style="word-wrap:break-word;">2917-delnp-2004-form-3.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjkxNy1kZWxucC0yMDA0LWZvcm0tNS5wZGY=" target="_blank" style="word-wrap:break-word;">2917-delnp-2004-form-5.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjkxNy1ERUxOUC0yMDA0LUdQQS0wOC0wNS0yMDA4LnBkZg==" target="_blank" style="word-wrap:break-word;">2917-DELNP-2004-GPA-08-05-2008.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjkxNy1kZWxucC0yMDA0LXBjdC0yMTAucGRm" target="_blank" style="word-wrap:break-word;">2917-delnp-2004-pct-210.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjkxNy1kZWxucC0yMDA0LXBjdC0zMDQucGRm" target="_blank" style="word-wrap:break-word;">2917-delnp-2004-pct-304.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjkxNy1kZWxucC0yMDA0LXBjdC0zMzgucGRm" target="_blank" style="word-wrap:break-word;">2917-delnp-2004-pct-338.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjkxNy1kZWxucC0yMDA0LXBjdC00MDkucGRm" target="_blank" style="word-wrap:break-word;">2917-delnp-2004-pct-409.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjkxNy1kZWxucC0yMDA0LXBjdC1ncGEucGRm" target="_blank" style="word-wrap:break-word;">2917-delnp-2004-pct-gpa.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjkxNy1ERUxOUC0yMDA0LVBldGl0aW9uLTEzNy0wOC0wNS0yMDA4LnBkZg==" target="_blank" style="word-wrap:break-word;">2917-DELNP-2004-Petition-137-08-05-2008.pdf</a></p>
		<br>
		<div class="pull-left">
			<a href="233486-a-method-of-controlling-the-fuelling-rate-to-an-internal-combustion-engine.html">&laquo; Previous Patent</a>
		</div>
		<div class="pull-right">
			<a href="233488-ortho-substituted-benzoic-acid-derivatives-for-the-treatment-of-insulin-resistance.html">Next Patent &raquo;</a>
		</div>			
	</div><!-- /span8 -->
	<div class="span4">
		<div class="well infobox">
			<table class="table table-condensed">
				<tr>
					<th>Patent Number</th>
					<td>233487</td>
				</tr>
				<tr>
					<th>Indian Patent Application Number</th>
					<td>2917/DELNP/2004</td>
				</tr>
				<tr>
					<th>PG Journal Number</th>
					<td>14/2009</td>
				</tr>
				<tr>
					<th>Publication Date</th>
					<td>27-Mar-2009</td>
				</tr>
				<tr>
					<th>Grant Date</th>
					<td>30-Mar-2009</td>
				</tr>
				<tr>
					<th>Date of Filing</th>
					<td>28-Sep-2004</td>
				</tr>
				<tr>
					<th>Name of Patentee</th>
					<td>KOWA CO., LTD.,</td>
				</tr>
				<tr>
					<th>Applicant Address</th>
					<td>6-29, NISHIKI 3-CHOME, NAKA-KU, NAGOYA-SHI, AICHI 460-8625, JAPAN.</td>
				</tr>
				<tr>
					<td colspan=2>
								<h5>Inventors:</h5>
								<table class="table">
									<tr>
										<th>#</th>
										<th>Inventor's Name</th>
										<th>Inventor's Address</th>
									</tr>

										<tr>
											<td>1</td>
											<td>NIICHIRO TAKANO</td>
											<td>5-1-302 MITOJIMA 1-CHOME,FUJI-SHI,SHIZUOKA 416-0921,JAPAN</td>
										</tr>
										<tr>
											<td>2</td>
											<td>HIROYUKI KAWASHIMA</td>
											<td>17-9 SUZUKAWANISHICHO 1-BAN,FUJI-SHI,SHIZUOKA 417-0014,JAPAN</td>
										</tr>
										<tr>
											<td>3</td>
											<td>YASUO SHINODA</td>
											<td>74 BABANCHO, SHIZUOKA-SHI, SHIZUOKA 420-0867, JAPAN</td>
										</tr>
										<tr>
											<td>4</td>
											<td>TOSHIO INAGI</td>
											<td>10-203 NISHIWAKACHO 6-CHOME, MISHIMA-SHI,SHIZUOKA 411-0038,JAPN</td>
										</tr>
								</table>
					</td>
				</tr>
				<tr>
					<th>PCT International Classification Number</th>
					<td>A61K 31/50</td>
				</tr>
				<tr>
					<th>PCT International Application Number</th>
					<td>PCT/JP03/04762</td>
				</tr>
				<tr>
					<th>PCT International Filing date</th>
					<td>2003-04-15</td>
				</tr>
				<tr>
					<td colspan=2>
						<h5>PCT Conventions:</h5>
						<table class="table">
							<tr>
								<th>#</th>
								<th>PCT Application Number</th>
								<th>Date of Convention</th>
								<th>Priority Country</th>
							</tr>

								<tr>
									<td>1</td>
									<td>60/372,416</td>
									<td>2002-04-16</td>
								    <td>U.S.A.</td>
								</tr>

						</table>
					</td>
				</tr>
			</table>
		</div><!-- /well -->
	</div><!-- /span4 -->
</div><!-- /row-fluid -->

        </div>

      </div><!--/row-->

      <footer class="footer">

        <style>
        .allindianpatents-footer { width: 320px; height: 50px; }
        @media(min-width: 500px) { .allindianpatents-footer { width: 468px; height: 60px; } }
        @media(min-width: 800px) { .allindianpatents-footer { width: 728px; height: 90px; } }
        </style>
        <center>
        </center>

        <p>&copy; All Indian Patents, 2013-2021.</p>
        <p>Patent data available in the public domain from Indian Patents Office, Department of Industrial Policy and Promotions, Ministry of Commerce and Industry, Government of India.</p>
      </footer>

    </div> <!-- /container -->

    <!-- Javascripts
    ================================================== -->
    <!-- Placed at the end of the document so the pages load faster -->
    <script src="../assets/application-95f297ff0d8d2015987f04b30593c800.js" type="text/javascript"></script>

    <!-- Start of StatCounter Code for Default Guide -->
    <script type="text/javascript">
    var sc_project=8902313; 
    var sc_invisible=1; 
    var sc_security="3c1f8147"; 
    var scJsHost = (("https:" == document.location.protocol) ?
    "https://secure." : "http://www.");
    document.write("<sc"+"ript type='text/javascript' src='" +
    scJsHost+
    "statcounter.com/counter/counter.js'></"+"script>");
    </script>
    <noscript><div class="statcounter"><a title="web stats"
    href="http://statcounter.com/free-web-stats/"
    target="_blank"><img class="statcounter"
    src="http://c.statcounter.com/8902313/0/3c1f8147/1/"
    alt="web stats"></a></div></noscript>
    <!-- End of StatCounter Code for Default Guide -->

    <script>
      (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
      (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
      m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
      })(window,document,'script','http://www.google-analytics.com/analytics.js','ga');

      ga('create', 'UA-244143-31', 'allindianpatents.com');
      ga('send', 'pageview');

    </script>

  </body>

<!-- Mirrored from www.allindianpatents.com/patents/233487-solid-dispersion-composition by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 13:44:08 GMT -->
</html>
